Narval

Private

ZapopanHealthcare & Life Scienceshttps://narvalbio.com/

Last Round

Accelerator

May 29, 2024

Total Funding Raised

$4.02M

Company Overview

Narval is a biotechnology company that develops synthetic Antibody Mimetic Proteins™ designed to replace conventional monoclonal antibodies in therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Defense Tech

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

synthetic antibody mimetic proteinsAMPsdrug discoveryAI drug discoveryin-silico drug designtherapeutic proteinslocalized drug deliverybiotechnologymarine biotechnologybiodefenseanimal healthgenerative AIprotein engineeringbiotech startupantibody alternatives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Narval Comps

Public and private peers based on sector, stage, and business model.

Narval comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Narval Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	May 29, 2024
Accelerator	Mar 11, 2024
Seed	Jul 10, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Alejandro Nuño Ayala

Founder Chief Scientific Officer

Founding Team

Jose Luis Nuno

Founder And CEO

Founding Team

Narval Investors

Notable investors and investment history

Narval investors
Investor	Rounds
Andreessen Horowitz	Seed
MedTech Innovator	Accelerator
Techstars	Accelerator
Fabric Ventures	Seed
Prelude	Seed
Motier Ventures	Seed
BioTools Innovator	Accelerator

View all Investors

Narval Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Narval Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Narval's valuation, stock price, and market status.

Firmographic Details

HeadquartersZapopan

Employee Range6

Year Founded2023

Last FundingMay 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.